Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune effector mechanisms in malaria.

M F Good1, D L Doolan

  • 1The Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital 4029, Queensland, Australia. michaelG@qimr.edu.au

Current Opinion in Immunology
|August 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgM in human immunity to <i>Plasmodium falciparum</i> malaria.

Science advances·2019
Same author

The Australasian contribution to malaria vaccine development.

Parasite immunology·2010
Same author

Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2.

Vaccine·2010
Same author

Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.

Vaccine·2009
Same author

Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Parasite immunology·2009
Same author

Experimental asexual blood stage malaria immunity.

Current protocols in immunology·2008
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

This review explores immunity to malaria parasites, focusing on immune responses to different Plasmodium stages. It also summarizes progress in developing vaccines targeting both pre-erythrocytic and erythrocytic stages.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Malaria is caused by Plasmodium parasites with complex life cycles.
  • Distinct parasite stages infect different host tissues, presenting unique antigens.
  • Understanding immunity to these stages is crucial for disease control.

Purpose of the Study:

  • To review recent advances in understanding immunity to pre-erythrocytic and erythrocytic malaria parasite stages.
  • To summarize progress in clinical trials of malaria vaccine candidates.

Main Methods:

  • Review of current literature on malaria immunity and vaccine development.
  • Analysis of immune mechanisms (cellular and molecular) against different parasite stages.
  • Summary of clinical trial data for vaccine candidates.

Related Experiment Videos

Main Results:

  • Pre-erythrocytic stage immunity involves CD8(+) T cells, IFN-gamma, nitric oxide, IL-12, and NK cells.
  • Erythrocytic stage immunity relies on antibodies, helper T cells, nitric oxide, and gammadelta T cells.
  • Vaccine candidates targeting both stages are in clinical trials, including heterologous prime/boost for pre-erythrocytic and MSP1 for erythrocytic stages.

Conclusions:

  • Significant progress has been made in understanding malaria immunity.
  • Vaccine development for both parasite stages shows promise, with ongoing clinical trials.
  • Targeting distinct Plasmodium stages offers potential for effective malaria control strategies.